Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...

With the market for anti-obesity drugs already worth billions, Aimee Donnellan’s Off the Scales is a timely exploration of ...

This book outlines the author’s reflections on various subjects including his childhood dream of becoming a fast bowler, cats, Buddha, the Karvi flower, writing, his friends, and life in Mumbai ...

BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology milestones include seven ...

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027 KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected in late-2027 KT-579 Phase 1 HV clinical trial ...

Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five additional Phase 3 azetukalner studies continuing to enroll patients in ...

Hanwha Corp., the de facto holding company of defense-to-shipbuilding conglomerate Hanwha Group, said Wednesday it will ...

A wild, often humorous ride through best-selling name brand writers and a maybe-murderous stalker who goes by the nickname ...

This isn’t a general chat tool repurposed for writing. It organizes the way books actually are: outlines, chapters, revisions ...

Bob Kocis shares the “Three Whys” framework that separates top sales performers, helping sellers close more deals and build ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...

BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology ...